A polymorphism in the gene encoding procolipase produces a colipase, Arg92Cys, with decreased function against long-chain triglycerides.
Type 2 diabetes mellitus is a multifactorial and polygenic disorder with increasing prevalence. Recently, a polymorphism in the gene encoding procolipase, a cysteine for arginine substitution at position 92, was associated with type 2 diabetes in two human populations. Because procolipase plays a critical role in dietary fat metabolism, polymorphisms that affect the function of procolipase could influence the development of type 2 diabetes. We hypothesized that the Arg92Cys polymorphism has functional consequences. To test our hypothesis, we expressed recombinant cysteine 92 (Cys92) procolipase in a yeast expression system and compared the function and stability of purified Cys92 with that of the more common arginine 92 (Arg92) procolipase. Cys92 fully restored the activity of bile-salt inhibited lipase with short- and medium-chain triglycerides but only had 50% of Arg92 function with long-chain triglycerides. After storage at 4 degrees C, Cys92 lost the ability to restore pancreatic triglyceride lipase activity with medium- and long-chain triglycerides. The loss of function correlated with the inability of Cys92 to anchor lipase on an emulsion surface and oxidation of the cysteine. No detectable degradation or intramolecular disulfide formation occurred in Cys92 after storage. Our findings demonstrate that the Arg92Cys polymorphism decreases the function of Cys92 colipase. This change may contribute to the development of type 2 diabetes.
D'Silva
Sheryl
S
Department of Pediatrics, Children's Hospital of Pittsburgh at University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Xiao
Xunjun
X
Lowe
Mark E
ME
D019943:Amino Acid Substitution; D001120:Arginine / Q000502:physiology; D003089:Colipases / Q000235:genetics* / Q000378:metabolism*; D003545:Cysteine / Q000502:physiology; D004792:Enzyme Precursors / Q000235:genetics* / Q000378:metabolism*; D004795:Enzyme Stability; D006801:Humans; D011110:Polymorphism, Genetic; D014280:Triglycerides / Q000378:metabolism*
D003089:Colipases; D004792:Enzyme Precursors; D014280:Triglycerides; C037107:procolipase; D001120:Arginine; D003545:Cysteine
Protein Expr Purif. 1998 Jun;13(1):36-40
9631512
Am J Physiol. 1995 Jul;269(1 Pt 2):R7-14
7631905
Gastroenterology. 1992 May;102(5):1654-9
1568575
Protein Sci. 1995 Jan;4(1):44-57
7773176
J Biol Chem. 2006 Mar 24;281(12):7793-800
16431912
Nature. 2006 Jan 19;439(7074):340-3
16421573
Protein Expr Purif. 1998 Jun;13(1):30-5
9631511
Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E948-53
15998659
EMBO J. 1997 Sep 15;16(18):5531-6
9312012
Obes Res. 1997 Jul;5(4):360-72
9285845
Physiol Behav. 1998 May;64(2):141-5
9662077
Gastroenterology. 1998 Nov;115(5):1179-85
9797373
J Biol Chem. 2002 Mar 1;277(9):7170-7
11751900
Nature. 1970 Aug 15;227(5259):680-5
5432063
Gastroenterology. 2000 Oct;119(4):943-8
11040181
Biochim Biophys Acta. 1999 Nov 23;1441(2-3):173-84
10570245
Biochemistry. 2002 Nov 19;41(46):13725-35
12427035
Gut. 1988 Mar;29(3):306-11
3356362
Mol Nutr Food Res. 2005 Oct;49(10):972-6
16189801
Physiol Behav. 2004 Dec 30;83(4):623-30
15621068
Gut. 2000 May;46(5):688-693
10764713
Biochemistry. 1990 Jan 23;29(3):823-8
2337598
Science. 2001 Feb 2;291(5505):881-4
11157169
Gut. 1982 Mar;23(3):243-6
7068048
J Lipid Res. 1998 Sep;39(9):1759-67
9741688
Biochim Biophys Acta. 1995 Mar 15;1247(2):185-94
7696307
Am J Physiol. 1990 Jul;259(1 Pt 2):R110-8
2375420